登录    
  
首页 > 期刊论文 > 论文摘要
吉非替尼耐药细胞株的筛选和基因谱表达研究
         
Selection and establishment of gefitinib-resistant PC9 cell line and its gene expression profile

摘    要
目的:从对吉非替尼(gefitinib)敏感的肺腺癌细胞株PC9中筛选并建立了6株gefitinib耐药细胞亚克隆并研究其生物学特性。方法:采用N-甲基-N'-硝基-N-亚硝基胍(MNNG)诱变筛选和有限稀释法进行耐药性亚克隆的单细胞培养,MTT法检测肿瘤细胞对gefitinib的敏感性和IC50,DNA微列阵检测耐药细胞株与野生型PC9细胞的基因表达差异,免疫组织化学法测定细胞外间质成分fibronectin和collagenⅣ的表达差异,FCM法进行细胞周期分析。结果:获得了对gefitinib具有较高耐药性的2个细胞株:PC9/G2和PC9/G4,尤其PC9/G2的IC50为7~10μmol/L,较野生型PC9细胞(IC50:0.03~0.05μmol/L)提高耐受性160~260倍。PC9的细胞倍增时间为(16.2±3.5)h,PC9/G2的倍增时间为(36.5±4.8) h。PC9/G2同PC9的基因表达谱存在明显差异,耐药细胞株PC9/G2的脂肪酸代谢和氧化磷酸化基因表达下降,糖酵解基因表达上升,核糖体各亚基蛋白表达下调,高尔基体和囊泡、笼形蛋白衣被小泡等相关基因表达上调,细胞蛋白分泌功能加强;泛素-蛋白酶体循环相关基因上调;DNA修复基因和解旋酶类基因表达上调;具有蛋白激酶活性的30个基因表达上调,11个基因表达下调;15个磷酸化蛋白磷酸酶活性的基因表达上调;具有GTP结合活性的基因21个表达上调,4个下调;涉及细胞骨架和细胞运动功能的8个基因上调;整合素β1亚基、类胰岛素受体、NFκB级联反应的正向调节因子表达上调。结论:成功建立了6株PC9细胞的gefitinib耐药细胞株,初步研究表明对gefitinib中度耐药可能与细胞外基质组分改变及其黏附信号通路有关,对gefitinib高度耐药则可能涉及替代性信号通道的激活和信号通道的下游激活。
标    签 肺肿瘤   抗药性   肿瘤   细胞   培养的   基因表达   吉非替尼   Lung neoplasms   Drug resistance   neoplasm   Cells   cultured   Gene expression   Gefitinib  
 
Abstract
Objective: To establish 6 subclones of gefitinib-resistant cells from gefitinib-sensitive lung adenocarcinoma cell line PC9 and study their biological characteristics.Methods: The PC9 cells were induced to mutate by a mutagen MNNG and selected.The subclone of gefitinib-resistant cell was obtained by limited dilution.The sensitivity and IC50 for gefitinib of various cell lines were determined by MTT assay.The different profile of gene expression between the wildtype PC9 cell and the gefitinib-resistant cells were determined by DNA microarray.Fibronectin and collagen Ⅳ expressions in various PC9 cell lines were checked by immunohistochemistry.Cell cycle was analyzed by flow cytometry.Results: Two resistant cell lines to gefitinib were obtained, named PC9/G2 and PC9/G4, respectively, and the IC50 for the gefitinib was 7-10 μmol/L, about 160 to 260 folds higher compared with wildtype PC9(IC50:0.03-0.05 μmol/L).The doubling time of PC9 cells and PC9/G2 cells were(16.2±3.5)h and(36.5±4.8)h, respectively.The gene expression profile had significant difference between wildtype PC9 cells and resistant PC9/G2 cells.Gene function annotation and grouping showed that in PC9/G2 cells fatty acid metabolism-and oxidative phosphorylation-related genes were down-regulated, while glycolysis-genes were up-regulated;the expressions of ribosomal subproteins were down-regulated, and the gene groups located in Golgi Stack, cisternae, clathrin-coated vesicle were up-regulated;the protein-secreting function was enhanced and ubiquitin-proteosome system was activated;DNA repair and helicase genes were also up-regulated.For the genes with protein kinase activity, 30 of them were up-regulated, while 11 of them were down-regulated;15 genes with phosphoprotein phosphatase activity were up-regulated.For the genes with GTP binding function, 21 of them were up-regulated, while 4 of them were down-regulated;8 genes related to cytoskeletal movement and cell adhesion were up-regulated;integrin beta1 subunit, insulin-like receptor and positive regulative factors for NFκB cascade were up-regulated.Conclusion: Six lines of gefitinib-resistant PC9 cells were successfully established.Our results suggested that moderate resistance to gefitinid might be related with extracellular matrix changes and adhesion signaling cascade, while high resistance may be due to activation of instead signaling pathway and the downstream molecules of signaling pathway.

中图分类号 R733.7   DOI 10.3781/.jissn.1000-7431.2008.07.003

 
  购买该论文  中国光学期刊网论文下载说明
      


所属栏目 基础研究

基金项目

收稿日期 2007/10/13

修改稿日期 2008/2/10

网络出版日期

作者单位点击查看


备注粟波(1969-),男(汉族),硕士,副研究员

引用该论文: SU Bo,SU Chun-xia,ZHANG Hai-ping,DENG Qin-fang,ZHAO Yin-min,ZHOU Cai-cun. Selection and establishment of gefitinib-resistant PC9 cell line and its gene expression profile[J]. Tumor, 2008, 28(7): 552~557
粟波,苏春霞,张海平,邓沁芳,赵印敏,周彩存. 吉非替尼耐药细胞株的筛选和基因谱表达研究[J]. 肿瘤, 2008, 28(7): 552~557


论文评价
共有人对该论文发表了看法,其中:
人认为该论文很差
人认为该论文较差
人认为该论文一般
人认为该论文较好
人认为该论文很好
分享论文
分享到新浪微博 分享到腾讯微博 分享到人人网 分享到 Google Reader 分享到百度搜藏分享到Twitter

参考文献
【1】PARK K,GOTO K.A review of the benefit-risk profile of gefitinib in Asian patients with advanced non-small cell lung cancer[J].CurrMed Res Opin,2006,22(3):561-573.
 
【2】PAO W,MILLER VA,POLITI KA,et al.A cquired resistance of lung ad enocarcinom as to gefitinib or erlotinib is associated with a second mutation in the EG FR kinase domain[J].PLoS Med,2005,2(3):e73.
 
【3】INUKA IM,TOYOOKA S,ITO S.Presence of epidermal growth factor receptor geneT 790M mutation as am in or clone in non-small cell lung cancer[J]. Cancer Re s,2006,166(16):7854-7858.
 
【4】JA IN A,TINDELL CA,LAU XI,et al.Epithelial membrane protein-1 is a biom arker of gefitinib resistance[J].ProcNatl AcadSci U S A,2005,102(33):1858-1863.
 
相关信息
   标题 相关频次
 Ⅳ型胶原对耐顺铂人肺腺癌细胞化疗诱导凋亡的影响
 11
 人肺腺癌吉非替尼耐药细胞株中微小RNA的表达谱
 10
 表皮生长因子受体基因CA简单重复序列多态性与晚期小细胞肺癌患者表皮生长因子受体酪氨酸激酶抑制剂临床疗效间的关系
 8
 蟾毒灵逆转肺腺癌H1975细胞对吉非替尼耐药的体内实验研究
 8
 血管内皮生长因子C过表达或抑制表达对人小细胞肺癌NCI-H446细胞生物学行为的影响
 8
 STI 571增强非小细胞肺癌对顺铂的敏感性
 6
 靶向肺癌的紫杉醇长循环脂质体抑瘤作用研究
 6
 靶向血管新生肽修饰的氧化铁纳米粒对荷瘤裸鼠磁热疗的研究
 6
 靶向肿瘤新生血管的顺磁性纳米脂质体在MRI诊断肺癌中的研究
 6
 干细胞标志CD90与人肺腺癌A549细胞顺铂耐药之间的关系
 6
 核仁磷酸蛋白和c-Src在耐药肺腺癌细胞中的表达及其与化疗耐药之间的关系
 6
 表皮生长因子受体信号通路与卵巢癌耐药细胞株SKOV3/DDP相关性的研究
 5
 肺癌中FHIT基因异常甲基化及其蛋白表达的意义
 5
 环氧合酶-2mRNA在非小细胞肺癌组织中表达的临床意义
 5
 美加明对人肺腺癌A549细胞增殖和迁移的影响
 5
 一种靶向肿瘤新生血管的新型长循环纳米脂质体的制备
 5
 survivin mRNA及蛋白在肺癌组织芯片中的表达及意义
 4
 cRGD-氧化铁纳米粒的构建及应用于核磁共振成像诊断中的动物研究
 4
 ERCC1、RRM1和BRCA1在非小细胞肺癌中的表达及预后意义
 4
 H2O2氧化刺激对紫杉醇耐药和敏感肺癌细胞的不同影响
 4
 H101溶瘤腺病毒联合长春瑞滨/顺铂一线治疗晚期非小细胞肺癌
 4
 KDR基因重组的T7噬菌体疫苗构建及其对小鼠Lewis肺癌抑制作用的研究
 4
 RNA干扰抑制Apollon表达联合川芎嗪可增强白血病细胞对化疗药物的敏感性
 4
 VEGF、ICAM-1和MMP-9在良恶性胸腔积液中的作用
 4
 长程多柔比星化疗富集乳腺肿瘤干细胞
 4
 大黄素诱导裸鼠体内白血病K562细胞凋亡过程中PI3K/AKT通路相关分子表达的变化
 4
 厄洛替尼治疗晚期非小细胞肺癌的临床研究
 4
 反转录病毒介导的HPV16 E6-siRNA对SiHa细胞增殖及抗药性的影响
 4
 非小细胞肺癌患者肿瘤浸润性淋巴细胞中T细胞克隆性增殖
 4
 非小细胞肺癌组织表皮生长因子受体基因突变的临床意义
 4

  热点专题


关于我们  |   联系我们  |   广告投放  |   《肿瘤》杂志社版权所有 《肿瘤》杂志社   © 中国 上海 2014.3
沪ICP备15036656号-2